Cogent Biosciences Inc share price logo

Cogent Biosciences Inc Share Price

NASDAQ: COGT

Mid Cap

$36.98

-0.27

(-0.71%)

as on

Cogent Biosciences Inc Stock Performance

as on April 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $36.74
    $37.99
    downward going graph

    0.65%

    Downside

    2.73%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.20
    $43.73
    downward going graph

    88.64%

    Downside

    18.25%

    Upside

    downward going graph

Cogent Biosciences Inc share price movements today

Previous Close
$37.25
Open
$37.48
Volume
1.1M
Day's Low - High
$36.74 - $37.99
52 Week Low - High
$4.20 - $43.73

Cogent Biosciences Inc Historical Returns

1 Month Return
+ 11.59 %
3 Month Return
-6.64 %
1 Year Return
+ 752.4 %
3 Year Return
+ 234.98 %
5 Year Return
+ 340.83 %

Cogent Biosciences Inc Stock Fundamentals & Key Indicators

Check Cogent Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.0B

EPS (TTM)

-2.1494

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-330.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-73.70%

Cogent Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cogent Biosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.0B340.83%NA0.00%
BUY$41.3B127.64%133.478.45%
BUY$112.2B100.4%28.8232.94%
NA$37.2BNA131.655.37%
BUY$79.4B48.8%18.0831.41%

Stock Returns calculator for Cogent Biosciences Inc Stock including INR - Dollar returns

The Cogent Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Cogent Biosciences Inc investment value today

Current value as on today

₹9,24,975

Returns

₹8,24,975

(+824.98%)

Returns from Cogent Biosciences Inc Stock

₹7,46,224 (+746.22%)

Dollar Impact

₹78,751 (+78.75%)

Analyst Recommendation on Cogent Biosciences Inc Stock

Based on 17 analysts

BUY

82.35%

Buy

17.65%

Hold

0.00%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Cogent Biosciences Inc. Average target price of $54.17

Cogent Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Cogent Biosciences Inc.

What analysts predicted

31.73%UPSIDE

Target Price

$54.17

Current Price

$36.98

Analyzed by

17 Analysts

Target

$54.17

Cogent Biosciences Inc target price $54.17, a slight upside of 31.73% compared to current price of $36.98. According to 17 analysts rating.

Cogent Biosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Cogent Biosciences Inc Stock has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-8% versus previous 30 day period

Cogent Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
5
-
-
-
4
-
-
-
-
Gross Profit
0
4
-1
-1
-1
2
-1
-1
-
-1
Operating Income
-59
-58
-62
-64
-75
-73
-74
-75
-83
-99
EBITDA
-58
-57
-61
-57
-74
-72
-73
-72
-78
-108
Interest Expense
-
4
-
-
-
-
-
0
1
1
Depreciation
0
0
1
1
1
1
1
1
1
1
Income Before Tax
-55
-54
-58
-58
-70
-67
-71
-73
-80
-102
Income Tax Expense
0
-3
-4
-
-
-
-
-
-
-
Net Income
-55
-54
-58
-58
-70
-67
-71
-73
-80
-102
Net Profit Margin
0.00%
-972.89%
0.00%
0.00%
0.00%
-1582.64%
0.00%
0.00%
0.00%
0.00%

Cogent Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
8
9
22
7
-
-
-
-
-
Gross Profit
6
8
9
22
-17
0
-5
-3
-4
-4
Operating Income
-19
-26
-36
-32
-82
-75
-147
-208
-275
-333
EBITDA
-18
-24
-34
-30
-34
-73
-141
-204
-271
-328
Interest Expense
-
-
-
-
0
3
3
-
-
3
Depreciation
-
1
1
1
0
0
5
3
4
4
Income Before Tax
-18
-25
-34
-31
-74
-72
-140
-192
-255
-328
Income Tax Expense
0
0
1
-1
-8
0
-7
-
-
-
Net Income
-18
-25
-34
-30
-74
-72
-132
-192
-255
-328
Net Profit Margin
-285.19%
-304.93%
-354.76%
-134.55%
-950.43%
0.00%
0.00%
0.00%
0.00%
0.00%

Cogent Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-54
-58
-58
-70
-67
-71
-73
-80
-102
Operating Cash Flow
-44
-52
-42
-51
-60
-66
-54
-64
-79
Investing Cash Flow
10
1
-84
60
61
69
8
-155
-322
Financing Cash Flow
-
214
0
0
0
24
47
217
588
Change in Cash
-33
162
-127
8
1
27
1
-2
186

Cogent Biosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-34
-31
-74
-72
-140
-192
-255
-328
Operating Cash Flow
-25
-32
-41
-35
-58
-118
-153
-207
-264
Investing Cash Flow
13
-10
23
8
-1
-124
-97
38
-399
Financing Cash Flow
0
70
0
232
37
163
163
214
878
Change in Cash
-13
27
-18
204
-22
-79
-87
44
214

Global Institutional Holdings in Cogent Biosciences Inc

Funds
Holdings
UBS Group AG
2.52%
VR Adviser, LLC
1.23%
Deerfield Management Co
5.57%
RTW INVESTMENTS, LLC
4.68%
TCG Crossover Management, LLC
3.62%

Cogent Biosciences Inc News & Key Events

  • img

    Today's Timeline - 10 November

    Mon, 08:13 PM

    -

    Cogent Biosciences shares surged 116% after positive Phase 3 PEAK trial results for bezuclastinib plus sunitinib in GIST patients.

Insights on Cogent Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, COGT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, COGT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, COGT stock has moved up by 134.9%

About Cogent Biosciences Inc

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.
OrganisationCogent Biosciences Inc
Headquarters275 Wyman Street, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Andrew R. Robbins M.B.A.
E-voting on sharesClick here to vote

Key Management of Cogent Biosciences Inc

Name

Title

Mr. Abb Hayden

Senior Vice President of Sales

Mr. Andrew R. Robbins M.B.A.

President, CEO & Director

Mr. John L. Green C.A., CPA

CFO & Principal Accounting Officer

Dr. John Edward Robinson Ph.D.

Chief Scientific Officer

Dr. Jessica Sachs M.D.

Chief Medical Officer

Ms. Christi Waarich

Senior Director of Investor Relations

Mr. Cole Pinnow

Chief Commercial Officer

Mr. Brad Barnett

Chief Technology Officer

Mr. Evan D. Kearns J.D.

Chief Legal Officer & Corporate Secretary

Ms. Erin Schellhammer

Chief People Officer

FAQs

What is Cogent Biosciences Inc share price today?

Cogent Biosciences Inc share price today is $36.98 as on at the close of the market. Cogent Biosciences Inc share today touched a day high of $37.99 and a low of $36.74.

What is the 52 week high and 52 week low for Cogent Biosciences Inc share?

Cogent Biosciences Inc share touched a 52 week high of $43.73 on and a 52 week low of $4.2 on . Cogent Biosciences Inc stock price today i.e. is closed at $36.98,which is 15.44% down from its 52 week high and 780.48% up from its 52 week low.

What is Cogent Biosciences Inc's market capitalisation today?

Cogent Biosciences Inc market capitalisation is $0.01T as on .

How to invest in Cogent Biosciences Inc Stock (COGT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cogent Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cogent Biosciences Inc Shares that will get you 0.0406 shares as per Cogent Biosciences Inc share price of $36.98 per share as on April 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cogent Biosciences Inc Stock (COGT) from India?

Indian investors can start investing in Cogent Biosciences Inc (COGT) shares with as little as ₹93.107 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.07 in Cogent Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Cogent Biosciences Inc share’s latest price of $36.98 as on April 21, 2026 at 1:29 am IST, you will get 0.2704 shares of Cogent Biosciences Inc. Learn more about fractional shares .

What are the returns that Cogent Biosciences Inc has given to Indian investors in the last 5 years?

Cogent Biosciences Inc stock has given 340.83% share price returns and 22.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?